Kooijman, M <br/><br/>
The risk-based approach to ATMP development - generally accepted by regulators but infrequently used by companies.  [electronic resource] 

 -  Regulatory toxicology and pharmacology : RTP  Nov 2013 
 - 221-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0295 
<br/><br/><label>Standard No.: </label>10.1016/j.yrtph.2013.07.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Drug Evaluation--methods<br/>Drug Evaluation, Preclinical<br/>Drug Industry<br/>Government Agencies<br/>Government Regulation<br/>Netherlands<br/>Risk Assessment